Louisiana State Employees Retirement System Invests $1.43 Million in Maximus, Inc. (NYSE:MMS)

Louisiana State Employees Retirement System bought a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 17,100 shares of the health services provider's stock, valued at approximately $1,434,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. VisionPoint Advisory Group LLC grew its position in shares of Maximus by 61.4% during the third quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider's stock worth $28,000 after acquiring an additional 145 shares during the last quarter. Anchor Investment Management LLC bought a new position in shares of Maximus during the fourth quarter worth about $32,000. Macquarie Group Ltd. bought a new position in Maximus in the 1st quarter valued at about $35,000. Planned Solutions Inc. bought a new position in Maximus in the 4th quarter valued at about $59,000. Finally, Captrust Financial Advisors grew its position in Maximus by 14.9% in the 2nd quarter. Captrust Financial Advisors now owns 1,303 shares of the health services provider's stock valued at $81,000 after buying an additional 169 shares in the last quarter. Institutional investors own 97.21% of the company's stock.

Maximus Price Performance

NYSE MMS traded up $1.40 on Friday, reaching $81.44. The company's stock had a trading volume of 277,679 shares, compared to its average volume of 249,132. Maximus, Inc. has a twelve month low of $72.39 and a twelve month high of $89.69. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.69 and a current ratio of 1.69. The stock has a market cap of $4.97 billion, a PE ratio of 26.97 and a beta of 0.72. The firm's 50 day moving average is $82.69 and its two-hundred day moving average is $81.21.


Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, beating analysts' consensus estimates of $1.28 by $0.06. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the prior year, the company earned $0.94 EPS. Maximus's revenue was up 6.2% on a year-over-year basis. As a group, sell-side analysts predict that Maximus, Inc. will post 5.41 EPS for the current year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend is Tuesday, May 14th. Maximus's payout ratio is 39.74%.

Insider Buying and Selling at Maximus

In other Maximus news, CFO David Mutryn sold 8,000 shares of the company's stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $83.95, for a total transaction of $671,600.00. Following the completion of the sale, the chief financial officer now directly owns 5,124 shares of the company's stock, valued at $430,159.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.40% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

MMS has been the subject of a number of recent analyst reports. Raymond James lowered shares of Maximus from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 3rd. StockNews.com upgraded shares of Maximus from a "hold" rating to a "buy" rating in a research report on Thursday, February 8th.

View Our Latest Report on Maximus

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

See Also

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

→ Dems have chosen Biden replacement? (From Paradigm Press) (Ad)

Should you invest $1,000 in Maximus right now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: